Senti Biosciences Holdings, Inc. — Form 8-K
Filed November 20, 2026 · analyzed by the 8-K Agent
8-K
▼ Likely negative
significance 48/100
What the filing says
KPMG LLP, Senti's principal accountant since before the April 2026 holding company reorganization, was dismissed on November 17, 2026. KPMG agreed with most of Senti's disclosure in the 8-K but explicitly stated it cannot confirm the audit committee's approval of the change and cannot agree or disagree with additional statements in Item 4.01(b). The specific reasons for dismissal and nature of disagreements are not detailed in this letter.
Why this rating
Auditor dismissal with stated disagreements signals potential accounting/governance friction; material for $53M company but no specific restatement/fraud disclosed yet
Extracted items
See more from November 20, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.